{"id": "1374842223699894280", "creation": 1616622904.0, "user_id": "442982534", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 7, "reply_count": 0, "like_count": 17, "quote_count": 0}}, "text": "Biopharma to Request US Emergency Use Authorization for COVID-19 Vaccine in April https://t.co/rhewW3gUYU\n\nCatalysts expected in 2021-2022 regarding Ocugen's pipeline therapeutics are discussed in a ROTH Capital Partners report.\n\n$OCGN #covid19 #vaccine #stocks Ocugen \n@Ocugen https://t.co/64wnbzgbpv", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#STOCKS"]}